UB Paderborn / Katalog / Suche / in CDI

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

The lancet oncology, 2017-07, Vol.18 (7), p.958-971

2017

Link zum Volltext

Verfügbarkeit prüfen

MRI abnormalities in children following sequential chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa for high-risk primitive neuroectodermal tumours of the central nervous system

Journal of medical imaging and radiation oncology, 2014-12, Vol.58 (6), p.683-690

2014

Link zum Volltext

Verfügbarkeit prüfen

Disordered activity? A review of the quality of epilepsy care provided to adults presenting to hospital with a seizure

British journal of hospital medicine (London, England : 2005), 2023-10, Vol.84 (10), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

The inbetweeners: a review of the transition from child into adult care for young people with chronic health conditions

British journal of hospital medicine (London, England : 2005), 2024-01, Vol.85 (1), p.1

2024

Link zum Volltext

Verfügbarkeit prüfen

OTHR-33. INTRODUCTION OF A MULTIDICIPLINARY NEURO ONCOLOGY LONG TERM FOLLOW UP CLINIC

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i154-i154

2022

Link zum Volltext

Verfügbarkeit prüfen

Initial response with paradoxical deterioration following bevacizumab for cerebral radiation necrosis

Pediatric blood & cancer, 2017-05, Vol.64 (5), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Care provided to young patients receiving systemic anticancer therapy

British journal of hospital medicine (London, England : 2005), 2019-11, Vol.80 (11), p.630

2019

Link zum Volltext

Verfügbarkeit prüfen

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse

Neuro-oncology (Charlottesville, Va.), 2022-01, Vol.24 (1), p.153-165

2022

Link zum Volltext

Verfügbarkeit prüfen

MB-61MEDULLOBLASTOMA - WHY IS THE 5-YEAR OVERALL PROGRESSION-FREE SURVIVAL NOT IMPROVING?

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii110.4-iii111

2016

Link zum Volltext

Verfügbarkeit prüfen

Childhood medulloblastoma—a single institution’s historical perspective on survival and functional morbidity

Child's nervous system, 2019-12, Vol.35 (12), p.2327-2338

2019

Link zum Volltext

Verfügbarkeit prüfen

Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics

Neuropathology and applied neurobiology, 2021-10, Vol.47 (6), p.736-747

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high‐dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour

Pediatric blood & cancer, 2017-11, Vol.64 (11), p.n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study

The lancet child & adolescent health, 2020-12, Vol.4 (12), p.865-874

2020

Link zum Volltext

Verfügbarkeit prüfen

Futile care in oncology: when to stop trying

The lancet oncology, 2001-12, Vol.2 (12), p.759-764

2001

Link zum Volltext

Verfügbarkeit prüfen

Delay in Transit: selected recommendations from the NCEPOD report on acute bowel obstruction

Frontline Gastroenterology, 2021-06, Vol.13 (3), p.186-192

2021

Link zum Volltext

Verfügbarkeit prüfen

LG-70DISSEMINATED LOW GRADE GLIOMA IN CHILDREN AND ADOLESCENTS- A RETROSPECTIVE REVIEW OF TREATMENT OUTCOME IN A SINGLE CENTRE

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii95.1-iii95

2016

Link zum Volltext

Verfügbarkeit prüfen

EPN-22RECURRENT PAEDIATRIC EPENDYMOMA: A RETROSPECTIVE REVIEW OF 194 CASES

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii35.2-iii35

2016

Link zum Volltext

Verfügbarkeit prüfen

MBCL-29. FEASIBILITY OF SCREENING AND REASONS FOR SCREENING FAILURES IN THE SIOPE PNET 5 MB TRIAL

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (suppl_2), p.i122-i123

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: Results of a Children’s Cancer and Leukaemia Group study

European journal of cancer (1990), 2011-06, Vol.47 (9), p.1389-1397

2011

Link zum Volltext

Verfügbarkeit prüfen

Lipofibromatosis of the knee in a 19-month-old child

Journal of pediatric surgery, 2012-05, Vol.47 (5), p.1028-1031

2012

Link zum Volltext

Verfügbarkeit prüfen

MB-79CENTRALISED MOLECULAR PATHOLOGY FOR RARE TUMOURS: A NATIONAL FEASIBILITY STUDY OF REAL-TIME MEDULLOBLASTOMA DIAGNOSTICS

Neuro-oncology (Charlottesville, Va.), 2016-06, Vol.18 (suppl 3), p.iii115.1-iii115

2016

Link zum Volltext

Verfügbarkeit prüfen

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma

Clinical & translational oncology, 2012-04, Vol.14 (4), p.271-279

2012

Link zum Volltext

Verfügbarkeit prüfen

Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

The lancet oncology, 2022-12, Vol.23 (12), p.1537-1546

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways

Acta neuropathologica communications, 2015-12, Vol.3 (1), p.86-86, Article 86

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study

MRI abnormalities in children following sequential chemotherapy, hyperfractionated accelerated radiotherapy and high-dose thiotepa for high-risk primitive neuroectodermal tumours of the central nervous system

Disordered activity? A review of the quality of epilepsy care provided to adults presenting to hospital with a seizure

The inbetweeners: a review of the transition from child into adult care for young people with chronic health conditions

OTHR-33. INTRODUCTION OF A MULTIDICIPLINARY NEURO ONCOLOGY LONG TERM FOLLOW UP CLINIC

Initial response with paradoxical deterioration following bevacizumab for cerebral radiation necrosis

Care provided to young patients receiving systemic anticancer therapy

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse

MB-61MEDULLOBLASTOMA - WHY IS THE 5-YEAR OVERALL PROGRESSION-FREE SURVIVAL NOT IMPROVING?

Childhood medulloblastoma—a single institution’s historical perspective on survival and functional morbidity

Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnostics

Impact of induction chemotherapy, hyperfractionated accelerated radiotherapy and high‐dose thiotepa on brain volume loss and functional status of children with primitive neuroectodermal tumour

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study

Futile care in oncology: when to stop trying

Delay in Transit: selected recommendations from the NCEPOD report on acute bowel obstruction

LG-70DISSEMINATED LOW GRADE GLIOMA IN CHILDREN AND ADOLESCENTS- A RETROSPECTIVE REVIEW OF TREATMENT OUTCOME IN A SINGLE CENTRE

EPN-22RECURRENT PAEDIATRIC EPENDYMOMA: A RETROSPECTIVE REVIEW OF 194 CASES

MBCL-29. FEASIBILITY OF SCREENING AND REASONS FOR SCREENING FAILURES IN THE SIOPE PNET 5 MB TRIAL

Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: Results of a Children’s Cancer and Leukaemia Group study

Lipofibromatosis of the knee in a 19-month-old child

The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy and Response Directed High Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy)

MB-79CENTRALISED MOLECULAR PATHOLOGY FOR RARE TUMOURS: A NATIONAL FEASIBILITY STUDY OF REAL-TIME MEDULLOBLASTOMA DIAGNOSTICS

Lack of T-cell responses following autologous tumour lysate pulsed dendritic cell vaccination, in patients with relapsed osteosarcoma

Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE

Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways

Suchergebnisse filtern